by Guillermo Beades, Esq. of Frier Levitt, LLC, Wiks Moffat, CHC, of HealthCare Compliance Network, LLC, and Jim Tudor, PCA, CPC, of HealthCare Compliance Network, LLC When the COVID-19 pandemic reached our shores, it instantly changed the way we... Read More
Blogs & Articles | COVID-19 Resources | Telehealth and Telemedicine

Despite the continuing increase in COVID-19 cases and the limit on gatherings, the Families First Coronavirus Response Act (FFCRA) will expire on December 31, 2020. Enacted in March 2020, the FFCRA provided extra expanded leave entitlements to... Read More
Blogs & Articles | COVID-19 Resources | Employment Matters | Healthcare

On May 15, 2020, Governor Murphy issued Executive Order No. 145 (“EO-145”), which lifts, subject to certain restrictions, the suspension of elective surgeries and invasive procedures effective May 26, 2020, ending a 60-day suspension imposed by... Read More
COVID-19 Resources | Healthcare Law | Healthcare Practice Compliance

As a first in the nation, criminal complaints were filed recently in Federal Court in Rhode Island for fraud related to the seeking of more than a half million dollars in loans pursuant to the Coronavirus, Aid, Relief, and Economic Security... Read More
Blogs & Articles | COVID-19 Resources | Employment Matters | Healthcare Law | Healthcare Litigation | Pharmacy Law | White Collar Defense and Government Investigation

Over the last few days, FDA has issued several guidance documents relating to compounding of certain aqueous injectable drugs by outsourcing facilities, State-licensed pharmacies and Federal facilities for duration of the COVID-19 public health... Read More
Blogs & Articles | Chain Pharmacies | Community, Retail Pharmacies | COVID-19 Resources | Healthcare | Hospitals and Healthcare Systems | Life Sciences | Pharmacy Law | Regulatory Compliance, including FDA, DEA and HIPAA | Section 340B In-House and Contract Pharmacies

Wholesale drug distributors need to maintain adequate track and trace documents, especially when acquiring and distributing COVID-19 therapies. The COVID-19 epidemic has sparked a demand for various drug products including, hydroxychloroquine. To... Read More
Blogs & Articles | COVID-19 Resources | Life Sciences | Manufacturers | Pharmacy Law | Regulatory Compliance, including FDA, DEA and HIPAA

Frier Levitt is pleased to announce that its COVID-19 Task Force assisted a national distributor to obtain an authorized distributorship of COVID-19 testing kits from a renowned South Korean manufacturer. This is a crucial development amid the... Read More
Employment Matters | Healthcare Law | Healthcare Litigation | Life Sciences | Manufacturers | Pharmacy Law | Recent Results

During this unprecedented time of the COVID-19 crisis, companies across every industry are taking immediate actions to help stem the spread of the virus and to ensure access to essential services.  These immediate efforts are only that much more... Read More
Blogs & Articles | Community, Retail Pharmacies | COVID-19 Resources | Defending Pharmacies in PBM Audits | Life Sciences | Pharmacy Law | Specialty Pharmacies

https://www.youtube.com/watch?v=AB_P7D2JF14&feature=youtu.be Frier Levitt Co-Founding Partner Jonathan Levitt, Esq. and Managing Partner John Morrone, Esq. discuss the COVID-19 pandemic as it pertains to providers. Recently, Medicare has... Read More
COVID-19 Resources | Healthcare | Healthcare Law | Hospitals and Healthcare Systems | Medical Spas and Cosmetic Services | Videos